Welcome to our dedicated page for KNOW LABS NEW news (Ticker: KNWND), a resource for investors and traders seeking the latest updates and insights on KNOW LABS NEW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect KNOW LABS NEW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of KNOW LABS NEW's position in the market.
Know Labs announced that NYSE Regulation has withdrawn its delisting determination and will lift the trading suspension of the company's common stock on the NYSE American. Trading is expected to resume on March 5, 2025, under the symbol 'KNW'.
While the immediate trading suspension is lifted, Know Labs remains under a compliance plan accepted by NYSE American on December 10, 2024. The company has until March 27, 2026, to regain compliance with continued listing standards under Sections 1003(a)(i), 1003(a)(ii), and 1003(a)(iii) of the NYSE American Company Guide. Failure to meet compliance standards or show consistent progress could result in renewed delisting proceedings.
Know Labs (OTC: KNWN) has received approval to begin trading on the OTCQB Venture Market effective February 26, 2025. The company, specializing in Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology, will trade under the symbol 'KNWN'. Following a reverse stock split announced by FINRA on February 18, 2025, the symbol temporarily carries a 'D' designation for 20 days from February 19, 2025.
The OTCQB market, recognized by the SEC as an established public market, requires companies to maintain current financial reporting, pass minimum bid price requirements, and undergo annual verification. This upgrade is expected to provide enhanced transparency, improved market depth disclosure, and potentially better liquidity for shareholders.
Know Labs (OTC: KNWND), a leader in Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology, has announced updates to its intellectual property portfolio. The company currently holds 325 patents (issued, pending, and in process) and has revealed a library of 1,022 trade secrets codified through the Tangibly platform.
According to an independent analysis by PatSnap, Know Labs' patent portfolio ranks first globally in specific categories of medical diagnostics and industrial process control. The company's IP strategy involves both patents and trade secrets, with the latter being disclosed publicly for the first time as part of their Know Labs Technology Licensing (KTL) initiative.
The slight reduction from previously reported 332 patent assets is attributed to combining provisional patents into utility patents and strategic abandonment of less critical pending patents. The company emphasizes that both patents and trade secrets will continue to grow as innovation progresses.
FAQ
What is the current stock price of KNOW LABS NEW (KNWND)?
